Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Opt Express ; 24(11): 11768-81, 2016 May 30.
Article in English | MEDLINE | ID: mdl-27410102

ABSTRACT

We built a two-mirror based X-ray split and delay (XRSD) device for soft X-rays at the Linac Coherent Light Source free electron laser facility. The instrument is based on an edge-polished mirror design covering an energy range of 250 eV-1800 eV and producing a delay between the two split pulses variable up to 400 femtoseconds with a sub-100 attosecond resolution. We present experimental and simulation results regarding molecular dissociation dynamics in CH3I and CO probed by the XRSD device. We observed ion kinetic energy and branching ratio dependence on the delay times which were reliably produced by the XRSD instrument.

4.
J Immunol ; 174(10): 6250-6, 2005 May 15.
Article in English | MEDLINE | ID: mdl-15879123

ABSTRACT

Factor H-related protein 5 (FHR-5) is a recently discovered member of the factor H (fH)-related protein family. FHR proteins are structurally similar to the complement regulator fH, but their biological functions remain poorly defined. FHR-5 is synthesized in the liver and consists of 9 short consensus repeats (SCRs), which display various degrees of homology to those of fH and the other FHR proteins. FHR-5 colocalizes with complement deposits in vivo and binds C3b in vitro, suggesting a role in complement regulation or localization. The current study examined whether rFHR-5 exhibits properties similar to those of fH, including heparin binding, CRP binding, cofactor activity for the factor I-mediated degradation of C3b and decay acceleration of the C3 convertase. rFHR-5 bound heparin-BSA and heparin-agarose and a defined series of truncations expressed in Pichia pastoris localized the heparin-binding region to within SCRs 5-7. rFHR-5 bound CRP, and this binding was also localized to SCRs 5-7. FHR-5 inhibited alternative pathway C3 convertase activity in a fluid phase assay; however, dissociation of the convertase was not observed in a solid phase assay. rFHR-5 displayed factor I-dependent cofactor activity for C3b cleavage, although it was apparently less effective than fH. In addition, we demonstrate association of FHR-5 with high density lipid lipoprotein complexes in human plasma. These results demonstrate that FHR-5 shares properties of heparin and CRP binding and lipoprotein association with one or more of the other FHRs but is unique among this family of proteins in possessing independent complement-regulatory activity.


Subject(s)
Blood Proteins/physiology , C-Reactive Protein/metabolism , Complement C3-C5 Convertases/antagonists & inhibitors , Complement Factor H/physiology , Complement Inactivator Proteins/physiology , Heparin/metabolism , Lipoproteins, HDL/metabolism , Blood Proteins/biosynthesis , Blood Proteins/genetics , Blood Proteins/metabolism , Complement C3-C5 Convertases/metabolism , Complement C3b/metabolism , Complement Factor H/metabolism , Complement Inactivator Proteins/biosynthesis , Complement Inactivator Proteins/genetics , Complement Inactivator Proteins/metabolism , Complement System Proteins , Consensus Sequence , Fibrinogen/physiology , Humans , Hydrolysis , Lipoproteins, HDL/blood , Peptide Fragments/biosynthesis , Peptide Fragments/genetics , Pichia/genetics , Protein Binding , Protein Structure, Tertiary , Recombinant Proteins/biosynthesis , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Recombinant Proteins/pharmacology , Repetitive Sequences, Amino Acid
5.
Am J Kidney Dis ; 40(1): 189-94, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12087578

ABSTRACT

BACKGROUND: Renovascular disease is a common cause of renal impairment and hypertension, particularly in the older population. Oligoanuric acute renal failure secondary to renal artery occlusion is not well recognized; however, it is potentially reversible if identified and treated. METHODS: Five patients presented to our institution with oligoanuric acute renal failure. Each had evidence of vascular disease, and a prerenal insult was identified. They were investigated with renal artery Doppler ultrasound or nuclear imaging before proceeding to percutaneous angioplasty and stent placement. RESULTS: The targeted kidney had relatively well-preserved renal size, and potential viability of the renal tissue was determined by nuclear scanning with parenchymal uptake of tracer. Percutaneous angioplasty and stent placement resulted in brisk reperfusion of the kidney and an immediate diuresis with improvement of renal function, avoiding supportive dialysis after the procedure. Contrast nephrotoxicity was identified in two of the five cases. CONCLUSION: Renal artery occlusion should be considered as a cause of oliguric acute renal failure, particularly in patients at high risk who present with a sudden deterioration of renal function, with nuclear imaging showing potentially viable renal tissue with relatively well-preserved renal size. Percutaneous revascularization should be considered in this group.


Subject(s)
Acute Kidney Injury/surgery , Angioplasty/methods , Arterial Occlusive Diseases/surgery , Renal Artery/surgery , Acute Disease , Acute Kidney Injury/diagnostic imaging , Aged , Aged, 80 and over , Arterial Occlusive Diseases/diagnostic imaging , Female , Humans , Kidney/blood supply , Kidney/diagnostic imaging , Kidney/surgery , Male , Middle Aged , Radioisotope Renography/methods , Renal Artery/diagnostic imaging , Ultrasonography
7.
Pathology ; 34(2): 138-43, 2002 Apr.
Article in English | MEDLINE | ID: mdl-12009095

ABSTRACT

AIMS: The reported association of glomerular disease with chronic lymphocytic leukaemia (CLL) is rare despite the relative frequency of this type of leukaemia. Hence, we have examined the renal biopsies in three patients with CLL and glomerulonephritis. METHODS: Renal biopsies were examined by light microscopy, immunofluorescence microscopy and electron microscopy. RESULTS: One of two patients with mild impairment of renal function and an active urinary sediment had ultrastructural features of idiopathic type I membranoproliferative glomerulonephritis (MPGN), and the other had features of fibrillary/ immunotactoid glomerulonephritis with deposits of IgG and C3. One patient with nephrotic syndrome had characteristic electron microscopic appearances of type III MPGN. In all three there was an association with monoclonal gammopathy. The parameters of glomerular damage improved in association with response to drug treatment of the CLL. CONCLUSION: There is a spectrum of types of MPGN seen in patients with CLL and there appears to be an association with the presence of monoclonal gammopathy. This is the first reported case of type III MPGN in CLL.


Subject(s)
Glomerulonephritis, Membranoproliferative/pathology , Kidney Glomerulus/pathology , Leukemia, Lymphocytic, Chronic, B-Cell/pathology , Vidarabine/analogs & derivatives , Adult , Aged , Antineoplastic Agents/therapeutic use , Chlorambucil/therapeutic use , Drug Therapy, Combination , Female , Glomerular Mesangium/ultrastructure , Glomerulonephritis, Membranoproliferative/complications , Glomerulonephritis, Membranoproliferative/drug therapy , Humans , Leukemia, Lymphocytic, Chronic, B-Cell/complications , Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy , Male , Microscopy, Fluorescence , Middle Aged , Paraproteinemias/complications , Paraproteinemias/drug therapy , Paraproteinemias/pathology , Prednisolone/therapeutic use , Treatment Outcome , Vidarabine/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...